Literature DB >> 28985752

Erratum to: MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis.

Yingmei Wang1,2, Limei Hu3,4, Ping Ji3,5, Fei Teng6, Wenyan Tian3, Yuexin Liu3,7, David Cogdell3, Jinsong Liu3, Anil K Sood8,9, Russell Broaddus3, Fengxia Xue10, Wei Zhang11,12.   

Abstract

Entities:  

Year:  2017        PMID: 28985752      PMCID: PMC5639573          DOI: 10.1186/s13045-017-0525-9

Source DB:  PubMed          Journal:  J Hematol Oncol        ISSN: 1756-8722            Impact factor:   17.388


× No keyword cloud information.

Erratum

The original article [1] contains an error whereby Fig. 2D mistakenly displays a duplicate image for the panels, ‘si-MIIP#1’ and ‘si-MIIP#2’. The correct version of Fig. 2D and its constituent panels can instead be viewed below.
  1 in total

1.  MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis.

Authors:  Yingmei Wang; Limei Hu; Ping Ji; Fei Teng; Wenyan Tian; Yuexin Liu; David Cogdell; Jinsong Liu; Anil K Sood; Russell Broaddus; Fengxia Xue; Wei Zhang
Journal:  J Hematol Oncol       Date:  2016-10-19       Impact factor: 17.388

  1 in total
  2 in total

1.  Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2.

Authors:  Guoxin Zhang; Hongli Li; Ruimei Sun; Peirui Li; Zhiyi Yang; Yuanyuan Liu; Zhaoyan Wang; Yuling Yang; Chonggao Yin
Journal:  J Cell Mol Med       Date:  2019-03-01       Impact factor: 5.310

2.  miR‑185‑5p inhibits F‑actin polymerization and reverses epithelial mesenchymal transition of human breast cancer cells by modulating RAGE.

Authors:  Chonggao Yin; Guoxin Zhang; Ruimei Sun; Xinting Pan; Xuewen Wang; Hongli Li; Yunbo Sun
Journal:  Mol Med Rep       Date:  2018-07-16       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.